Abstract
AbstractAn alternative and efficient route has been derived to generate the high valent [Mn(V)=O(m‐Cl‐salicylate)]+ intermediates with a series of non‐heme neutral ligand frameworks at 20 °C. The current method provides an advantage with feasibility in maintaining stoichiometric oxidant ratios along with the crucial variations of the salicylate moieties in tuning the reactivity of Mn(V)=O species. An in‐depth analysis of the Hammett studies revealed that the bound 5‐X‐salicylate (X=Cl, and NO2) drastically alters the corresponding Mn(V)=O's reactivity rates. In contrast, variations in the parent ligand frameworks resulted in consistent ρ values with increased lifetimes depicting the ligand's role in stabilization. Lastly, the complexes have been characterized to promote oxidative stress and prevent the proliferation of cancer cells effectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
